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Abstract
Iridoids are secondary metabolites with several biological activities. They are often found in species of the genus Tabebuia Gomes
ex A.P. de Candolle. Tabebuia aurea (Silva Manso) Benth. & Hook. F. ex S. Moore, Bignoniaceae, is used to treat snake bites in
traditional medicine. This study aimed to isolate the specioside - an the iridoid glycoside - from T. aurea, as well as investigate its
potential biological properties, including anti-inflammatory, antibacterial, antibiofilm, cytotoxic, anti-Trichomonas vaginalis and
antitrypanosomal activities. Specioside inhibited leucocyte recruitment into the peritoneal cavity in mice injected with carrageenan,
data that demonstrated its anti-inflammatory potential. However, the additional evaluated biological properties were negligible.
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Introduction
Iridoids are natural constituents in a large number of plant
families, including Bignoniaceae, Scrophulariaceae,
Rubiaceae, Verbenaceae, Oleaceae, Acanthaceae,
Pedaliaceae, Labiatae, Loganiaceae, Ericaceae, Liliaceae,
Apocynaceae and Euphorbiaceae (Cao et al. 2019). These
compounds are exhibit a wide range of biological and phar-
macological activities, such as anti-inflammatory,
antiamoebic, anti-diabetic, neuroprotective, anti-cancer, anti-
obesity, hepatoprotective and cardiovascular (hypotensive,
antiarrhythmic, increase in coronary perfusion rate) properties
(Ghisalberti 1998; Bharti et al. 2006; Dinda et al. 2007; Huang
et al. 2019).
Specioside (1), 6-O-(p-coumaroyl)-catalpol was first isolat-
ed from the bark of Catalpa speciosa (Warder ex Barney)
Warder ex Engelm., Bignoniaceae (El-Naggar and Doskotch
1980). It is an important iridoid of the Tabebuia Gomes ex
A.P. de Candolle genus, Bignoniaceae, having been described
from T. argentea Britt., T. rosea (Bertol.) DC., T. pentaphylla
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Hemsl. and T. aurea (Silva Manso) Benth. & Hook. F. ex S.
Moore (Cao et al. 2019; Malange et al. 2019). This compound
has already been identified in some species from other genera,
including Ailanthus integrifolia Lamk, Buddleja alternifolia
Maxim, Kigelia africana (Lam.) Benth, Verbascum
phlomoides L. and Veronica peregrina L., amongst others
(Cao et al. 2019). In addition, specioside shows antioxidant
activity (Elusyian et al. 2011); in the free-living nematode
Caenorhabditis elegans, it alleviates stress and prolongs
lifespan (Ashtana et al. 2015).
Tabebuia aurea is used in traditional medicine to treat
snake bites. In experimental mice, its hydroethanolic extract
decreases the inflammatory, haemorrhagic and myotoxic ac-
tivities induced by the venom of Bothrops neuwiedi Wagler,
1824 (Reis et al. 2014). Additionally, this extract reduces the
paw edema induced by the venom of Bothrops moojeniHoge,
1966 (Carollo et al. 2015), as well as the hyperalgesia and
neuronal injury induced by Bothrops mattogrossensis
Amaral, 1925 venom (Malange et al. 2019). Although
T. aurea extracts are effective in reducing inflammation
caused by snake venom, specioside, present in these extracts,
had not yet been tested as anti-inflammatory agent.
Although iridoids have a wide range of biological activi-
ties, including anti-diabetic, anti-inflammatory, immunosup-
pressive, neuroprotective, anti-cancer and anti-obesity, there
are few studies on the biological activities of specioside. Thus,
the present study aimed to isolate the specioside from the
barks of T. aurea and evaluate its pharmacological potential
in series of simple bioassays to examine its anti-inflammatory,
cytotoxic, antibacterial, antibiofilm, cytotoxic, anti-
Trypanosoma cruzi and anti-Trichomonas vaginalis activities.
Material and methods
Stem barks from Tabebuia aurea (Silva Manso) Benth. &
Hook. F. ex S. Moore, Bignoniaceae, were collected in 2017
in Campo Grande, MS, Brazil (20°44′28”S, 54°64′64”W) at
an altitude of 615 m above sea level. Avoucher specimen was
deposited in the CGMS herbarium at the Federal University of
Mato Grosso do Sul (number 74328). It was identified by
Professor Flavio Macedo Alves, based on the comparison
with herbarium samples, a specialised bibliography (Gentry
1992) and the type specimens. The material was dried, pow-
dered and 2.90 kg was extracted with ethanol:water (7:3, v/v;
2.16 l) by percolation. The extract was concentrated and
lyophilised to yield a crude extract (606.49 g). A portion of
this extract (189.11 g) was solubilised in methanol and main-
tained in contact with Amberlite XAD2 for 2 h with agitation.
Subsequently, the Amberlite XAD2 was washed with
deionised water (approximately 5 l) to remove the sugars,
followed by washing with methanol (approximately 5 l) to
obtain the methanolic fraction. This fraction was concentrated
and precipitated using deionised water. The precipitate was
removed and dried by lyophilisation to obtain the iridoid
specioside (18.65 g).
The iridoid was analysed by liquid chromatography-diode
array detection-tandem mass spectrometry (LC-DAD-MS/
MS) with UFLC Shimadzu Prominence equipment coupled
to a DAD and MicrOTOF mass spectrometer, using a Kinetex
C18 column (2.6 μm, 100 × 3.01 mm, Phenomenex) and the
following elution gradient profile 0–10 min: 6.0% B; 10–
12 min: 6.0–40.0% B; 12–13 min: 40.0–100.0% B; 13–
15 min: 100.0–6.0% B (solvent B: acetonitrile, solvent A:
water; both solvents were added to 0.1% formic acid). The
analyses were acquired in negative and positive ion modes.
Nitrogen was applied as a nebuliser gas (4 Bar), dry gas (9 l/
min) and collision gas. The capillary voltage was 3.5 kV. The
compound was solubilised at 0.3 mg/ml (methanol and water,
6:4 v/v), filtered (Millex, PTFE, 0.22μm× 3.0mm,Millipore)
and injected on the system. The injection volume, flow rate
and oven temperature were 1 μl, 0.3 ml/min and 50 °C, re-
spectively. The iridoid was also analysed by nuclear magnetic
resonance (NMR; 1H, 13C, DEPT 135°, COSY, HMQC and
HMBC) on a Bruker DRX500 spectrometer (1H at 500 MHz
and 13C at 125 MHz). Chemical shifts (δ) were expressed in
ppm value relative to TMS. The sample was solubilised in
CD3OD (δ 3.31). NMR data are included as Supplementary
Material.
The in vivo study was approved by the Ethics Committee
on Animal Experimentation of the UFMS (Protocol 588/
2014; May, 52,014) and was conducted in accordance with
the National Institutes of Health regulations on the use and
care of animals for scientific purposes. For carrageenan-
induced leucocyte recruitment into the peritoneal cavity assay,
male Swiss mice (18–25 g; n = 9 per group; four groups) were
used. The animals were obtained from the Central Animal
House of UFMS and housed under a 12 h light:12 h dark cycle
before starting the experiments, at 22 ± 2 °C, with food and
water available ad libitum. Six hours before each experiment,
the animals received only water to avoid food interference
with substance absorption. To induce leucocyte recruitment
into the peritoneal cavity, the animals were pre-treated for
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60 min with vehicle (water), specioside (50 mg/kg, p.o.) or
indomethacin (15mg/kg, p.o.). Subsequently, carrageenan 1%
(w/v, 0.5 ml, i.p.) diluted in 0.9% sterile saline solution was
injected. Four hours post-injection of stimulus, the mice were
euthanised in a CO2 chamber, and the cells from the peritoneal
cavity were harvested by injecting 3 ml phosphate-buffered
saline (PBS) that contained 30 U (units) heparin (Basel,
Switzerland). The suspension was aspirated with a syringe,
diluted (1:20, v/v) in Turk’s solution (0.2% crystal violet dye
in 30% acetic acid), and the total cells were counted in a
Neubauer chamber. For differential cell counts, the prepara-
tions were stained with Instant-Prov (Newprov). These cells
were classified as either polymorphonuclear or mononuclear
based on conventional morphological criteria.
The data of carrageenan-induced leucocyte recruitment as-
say are shown as the mean ± S.E.M. Statistical differences
were analysed by one way ANOVA followed by the Tukey’s
test.
The specioside cytotoxicity was examined using a MTT
assay (Invitrogen, Eugene, OR, USA) (Mosmann 1983).
HeLa cells (cervical cancer cell line) and HaCaT (human
keratinocytes cell line) were kindly provided by Dr. Luisa L.
Villa (ICESP, School of Medicine, University of São Paulo/
Brazil) and Dr. Silvya S. Maria-Engler (Faculty of
Pharmaceutical Sciences, University of São Paulo), respec-
tively. Cells were cultured in Dulbecco’s modified Eagle’s
medium (D6429; Sigma-Aldrich).
For the antibacterial, biofilm formation and eradication of
established biofilm assays, Staphylococcus aureus (S. aureus)
ATCC 25904 (clumping factor posit ive variant) ,
Staphylococcus epidermidis (S. epidermidis) ATCC 35984
(isolated from catheter sepsis in the state of Tennessee,
USA) and Pseudomonas aeruginosa (P. aeruginosa) ATCC
27853 (isolated from blood culture) were cultivated inMueller
Hinton (MH) agar at 37 °C. Bacterial suspensions (3 × 108
colony-forming units [CFU]/ml) were prepared in 0.9% sterile
saline. Antibiofilm activity was evaluated using a crystal vio-
let assay according to Trentin et al. (2011), whilst the viability
of biofilm cells was measured by the MTT assay. Dimethyl
sulfoxide (DMSO) was used as negative control, and vanco-
mycin (for S. aureus), rifampicin (for S. epidermidis) and
gentamycin (for P. aeruginosa) were included as positive
controls.
The antitrypanosomal assay utilised T. cruzi isolated from
Didelphis marsupialis. The isolation was performed at the
University of Carabobo, Venezuela. Axenic culture was
established in liver infusion tryptose (LIT) medium, and a
clonal population was obtained. The T. cruzi clone Dm28c
was biologically characterised, and an aliquot was kindly pro-
vided by the Carlos Chagas-Fiocruz Institute/PR.
Epimastigote forms of T. cruzi, clone Dm28c, were kept at
28 °C in LIT medium supplemented with 10% inactivated
foetal bovine serum. Parasites in the exponential growth phase
were used for the experiments. The antiproliferative activity
evaluated by the MTS (3-(4,5-dimetilthyazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)
assay, according to Henriques et al. (2011). The cells were
seeded in 96-well tissue plates at 1 × 106 cells/ml and incubat-
ed with specioside (93 or 290 μM; contained 1.5% DMSO) at
28 °C for 72 h. A negative control (1.5% DMSO) and positive
controls with different benznidazole concentrations (5 to
80 μM) were also included. Then, MTS/PMS (40 μg and
0.92 μg per well, respectively) were added to each well, and
the plate was incubated at 28 °C for 4 h. The absorbance was
evaluated at 490 nm. In parallel, we performed tests of each
treatment fixed with 4% paraformaldehyde prior to the addi-
tion of MTS/PMS (basal absorbance control).
The T. vaginalis isolate 30236 (JH 31A #4, from the
American Type Culture Collection ([ATCC], USA) was used
in the anti-Trichomonas vaginalis assay. Parasites were cul-
tured in vitro in trypticase-yeast extract-maltose (TYM) me-
dium (pH 6.0) supplemented with 10% (v/v) heat-inactivated
adult bovine serum, and incubated at 37 °C (Diamond 1957).
Trophozoites in the logarithmic growth phase - and exhibiting
more than 95% viability and normal morphology - were har-
vested, centrifuged and resuspended in the new TYMmedium
for the experimental assays. In the 96-well microplate, 50 μl
specioside (at 100 μM) was added to 150 μl of a trophozoite
suspension (2 × 105 trophozoites/ml). The plate was incubated
for 24 h at 37 °C with 5% CO2. Subsequently, the exclusion
dye trypan blue was added, and the viable number of tropho-
zoites was counted with a Neubauer camera. Three controls
were performed: negative control (trophozoites without treat-
ment), vehicle control (0.6% DMSO) and positive control
(100 μM metronidazole).
Results and discussion
Extracts from Tabebuia species have shown anti-inflammato-
ry, antioxidant, anti-hemorrhagic, anti-diabetic, anti-cancer,
anti-obesity, antibacterial and antihyperalgesic activities
(Ospina et al. 2013; Huang et al. 2019; Malange et al. 2019).
The Tabebuia genus has a storage capacity for iridoid glyco-
sides, which has been described as important chemotaxonomy
markers (Santos et al. 2017).
In the present study, compound 1, namely the iridoid iso-
lated from T. aurea, was identified as specioside by compari-
son of its physical and spectroscopic properties with those
previously reported in the literature (Compadre et al. 1982).
This compound was analysed by NMR (Supplementary
Material) and LC-DAD-MS. In the LC-DAD-MS/MS analy-
sis, the compound showed a retention time of 21.9 min, two
absorption bands at 299 and 312 nm in its UV spectrum and
the deprotonated molecule anion at m/z 507.1498 [M-H]−,
which was compatible with the molecular formula
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C24H28O12. The [M-H]
− yielded the fragment ions at m/z
345.0997 and 163.0391 (coumaric acid moiety), which are
relative to the eliminations of a hexose molecule and a glyco-
sylated iridoid, respectively. Notably, in the present study,
specioside (1) was isolated from T. aurea with a yield 20-
times higher than that reported by Compadre et al. (1982).
Previous studies reported a wide range of bioactivities for
iridoids, including antimicrobial, cytotoxic, hypotensive, sed-
ative, choleretic, hepatoprotective, anti-inflammatory,
antiallergic, anti-arthritic, wound-healing, antispasmodic and
antioxidative (Ghisalberti 1998; Bharti et al. 2006; Dinda et al.
2007). Thus, it is crucial to explore the biological potential of
these compounds because they may represent a relevant
starting point for the development of novel drugs. Few studies
have investigated the potential activities of specioside, the
iridoid isolated in this study.
The effect of specioside on leucocyte recruitment into the
peritoneal cavity was evaluated in mice injected with 1% car-
rageenan (Fig. 1). Treatment with specioside (50 mg/kg) re-
sulted in an 80.0% inhibition of leucocyte infiltration, whilst
indomethacin (15 mg/kg) reduced the leucocyte migration by
56% when compared to the vehicle (water 10 ml/kg). Reis
et al. (2014) evaluated the effect of the hydroethanolic extract
from T. aurea on polymorphonuclear recruitment into the peri-
toneal cavity in mice injected with B. neuwiedi snake venom
and observed that 100 mg/kg of this extract reduced the re-
cruitment by 32.2%. Thus, our result demonstrates the anti-
inflammatory potential of specioside and highlights that the
isolated compound presents a promising activity.
In the present study, the specioside did not show activity
against HeLa and HaCaTcells. Xu et al. (2016) also noted that
no cytotoxic activity by specioside on HepG2 and HeLa cells.
Additionally, although some studies demonstrated that the an-
timicrobial activity of iridoids, specioside did not show anti-
bacterial effects against planktonic cells of S. aureus,
S. epidermidis or P. aeruginosa (Tab. 1). It was also unable
to inhibit biofilm formation or eradicate the biofilm already
formed by these bacterial strains. Our results are consistent
with Compadre et al. (1982), who demonstrated that
specioside is not effective against Escherichia coli, Sarcina
lutea, Candida albicans and S. aureus.
Concerning the antitrypanosomal property, compound 1
did not show activity at the tested concentrations.
Furthermore, in the anti-T. vaginalis assay, it also failed to
inhibit this protozoan.
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